Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1980 | 12-1979 | 12-1978 | |
| Sales | 3,029,300 | 2,746,000 | 2,399,300 |
| Cost of Goods | 1,449,000 | 1,323,800 | 1,148,000 |
| Gross Profit | 1,580,300 | 1,422,200 | 1,251,300 |
| Operating Expenses | 1,095,200 | 976,000 | 878,900 |
| Operating Income | 485,100 | 447,000 | 372,400 |
| Interest Expense | 107,800 | 87,700 | 71,600 |
| Other Income | 32,700 | 6,300 | 18,500 |
| Pre-tax Income | 410,000 | 365,600 | 319,300 |
| Income Tax | 149,000 | 120,600 | 105,200 |
| Net Income Continuous | 253,900 | 237,900 | 209,900 |
| Net Income | $253,900 | $237,900 | $209,900 |
| EPS Basic Total Ops | 0.07 | N/A | N/A |
| EPS Basic Continuous Ops | 0.07 | N/A | N/A |
| EPS Diluted Total Ops | 0.07 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.07 | N/A | N/A |
| EBITDA(a) | $485,100 | $447,000 | $372,400 |